FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anita Langerød

Research Profile

Disorders

Chemicals & Drugs

Procedures

Physiology

Devices

Oligonucleotide Array Sequence Analysis

Genes & Molecular Sequences

Genes, p53

Concepts & Ideas

Anatomy

Tumor Cell Line

Co-author Network

Publications

TOP 3
Helene Tuft Stavnes; Anne-Lise Børresen-Dale; Arild Holth; Anita Langerød; Dag André Nymoen; Ben Davidson
AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma.
William A Freed-Pastor; Anita Langerød; Arnold J Levine; Wencheng Li; Scott W Lowe; Hideaki Mizuno; Sung-Hwan Moon; Timothy F Osborne; Alla Polotskaia; Jill Bargonetti; Anthony Barsotti; Mina J Bissell; Anne-Lise Børresen-Dale; Agustin Chicas; Ruth Rodriguez-Barrueco; Jose M Silva; Bin Tian; Xi Zhao; Carol Prives
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway.
Rachael Natrajan; Jose Palacios; Monica Arnedos; Felipe C Geyer; Hugo Horlings; Bas Kreike; Maryou B K Lambros; Anita Langerød; Alan Mackay; Fabien Reyal; Kai-Keen Shiu; Marc J van de Vijver; Britta Weigelt; Daniel Wetterskog; Paul M Wilkerson; Jorge S Reis-Filho
Functional characterization of the 19q12 amplicon in grade III breast cancers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anita Langerød (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Helene Tuft Stavnes; Anne-Lise Børresen-Dale; Arild Holth; Anita Langerød; Dag André Nymoen; Ben Davidson
AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma.
Virchows Archiv : an international journal of pathology 2013;462(2):163-73.
2012: William A Freed-Pastor; Anita Langerød; Arnold J Levine; Wencheng Li; Scott W Lowe; Hideaki Mizuno; Sung-Hwan Moon; Timothy F Osborne; Alla Polotskaia; Jill Bargonetti; Anthony Barsotti; Mina J Bissell; Anne-Lise Børresen-Dale; Agustin Chicas; Ruth Rodriguez-Barrueco; Jose M Silva; Bin Tian; Xi Zhao; Carol Prives
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway.
Cell 2012;148(1-2):244-58.
2012: Rachael Natrajan; Jose Palacios; Monica Arnedos; Felipe C Geyer; Hugo Horlings; Bas Kreike; Maryou B K Lambros; Anita Langerød; Alan Mackay; Fabien Reyal; Kai-Keen Shiu; Marc J van de Vijver; Britta Weigelt; Daniel Wetterskog; Paul M Wilkerson; Jorge S Reis-Filho
Functional characterization of the 19q12 amplicon in grade III breast cancers.
Breast cancer research : BCR 2012;14(2):R53.
2011: Alexandra J van den Broek; Laura J van't Veer; Linde M Braaf; Annegien Broeks; Sander V M Canisius; Hugo M Horlings; Anita Langerød; Marjanka K Schmidt
Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.
Breast cancer research and treatment 2011;130(2):599-608.
2011: Tiffany Hung; Manolis Kellis; Seung K Kim; Ashley K Koegel; Benjamin Kong; Yojiro Kotake; Anita Langerød; Michael F Lin; Nilay Shah; Saraswati Sukumar; Christopher B Umbricht; Marc van de Vijver; Pei Wang; Yu Wang; Yulei Wang; Michael L Whitfield; David J Wong; Yue Xiong; Anne-Lise Børresen-Dale; Gavin D Grant; Hugo M Horlings; Howard Y Chang
Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters.
Nature genetics 2011;43(7):621-9.
2011: Suresh Anaganti; Lynnette Fernández-Cuesta; Anita Langerød; Pierre Hainaut; Magali Olivier
p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines.
Cancer letters 2011;300(2):215-24.
2011: Xi Zhao; Einar Andreas Rødland; Therese Sørlie; Bjørn Naume; Anita Langerød; Arnoldo Frigessi; Vessela N Kristensen; Anne-Lise Børresen-Dale; Ole Christian Lingjaerde
Combining gene signatures improves prediction of breast cancer survival.
PloS one 2011;6(3):e17845.
2010: Hege G Russnes; Hans Kristian Moen Vollan; Ole Christian Lingjaerde; Alexander Krasnitz; Pär Lundin; Bjørn Naume; Therese Sørlie; Elin Borgen; Inga H Rye; Anita Langerød; Suet-Feung Chin; Andrew E Teschendorff; Philip J Stephens; Susanne Månér; Ellen Schlichting; Lars O Baumbusch; Rolf Kåresen; Michael P Stratton; Michael Wigler; Carlos Caldas; Anders Zetterberg; James Hicks; Anne-Lise Børresen-Dale
Genomic architecture characterizes tumor progression paths and fate in breast cancer patients.
Science translational medicine 2010;2(38):38ra47.
2010: Michala de Neergaard; Jiyoung Kim; René Villadsen; Agla J Fridriksdottir; Fritz Rank; Vera Timmermans-Wielenga; Anita Langerød; Anne-Lise Børresen-Dale; Ole W Petersen; Lone Rønnov-Jessen
Epithelial-stromal interaction 1 (EPSTI1) substitutes for peritumoral fibroblasts in the tumor microenvironment.
The American journal of pathology 2010;176(3):1229-40.
2010: M Bocanegra; Anna Bergamaschi; Young-Hak Kim; M A Miller; A B Rajput; J Kao; Anita Langerød; Wonshik Han; D-Y Noh; Stefanie S Jeffrey; David Huntsman; Anne-Lise Børresen-Dale; Jonathan R Pollack
Focal amplification and oncogene dependency of GAB2 in breast cancer.
Oncogene 2010;29(5):774-9.
2010: Henne Holstege; Hugo M Horlings; Arno Velds; Anita Langerød; Anne-Lise Børresen-Dale; Marc J van de Vijver; petra nederlof; Jos Jonkers
BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.
BMC cancer 2010;10():654.
2009: Wenjing Zhou; Anne-Lise Børresen-Dale; Eldri U Due; Aslaug A Muggerud; Therese Sørlie; Phuong Vu; Fredrik Wärnberg; Anita Langerød
Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution.
Molecular oncology 2009;3(3):214-9.
2008: Anna Bergamaschi; Young H Kim; Kevin A Kwei; Yoon La Choi; Melanie Bocanegra; Anita Langerød; Wonshik Han; Dong-Young Noh; David G Huntsman; Stefanie S Jeffrey; Anne-Lise Børresen-Dale; Jonathan R Pollack
CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer.
Molecular oncology 2008;2(4):327-39.
2008: Ruth Holm; Irene Kraus; Hanne Skomedal; Anita Langerød; Gunnar Kristensen; Heidi Lyng
Human papillomavirus DNA and e6/e7 mRNA status in relation to survival of patients treated for cervical squamous cell carcinoma.
The open virology journal 2008;2():74-81.
2008: Alexandra M Pietersen; Hugo M Horlings; Michael Hauptmann; Anita Langerød; Abderrahim Ajouaou; Paulien Cornelissen-Steijger; Lodewyk F A Wessels; Jos Jonkers; Marc J van de Vijver; Maarten van Lohuizen
EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer.
Breast cancer research : BCR 2008;10(6):R109.
2007: Montserrat Garcia-Closas; Vessela N Kristensen; Anita Langerød; Ying Qi; Meredith Yeager; Laurie Burdett; Robert Welch; Jolanta Lissowska; Beata Peplonska; Louise A Brinton; Daniela S Gerhard; Inger Torhild Gram; Charles M Perou; Anne-Lise Børresen-Dale; STEPHEN CHANOCK
Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer.
International journal of cancer. Journal international du cancer 2007;121(11):2532-8.
2007: Montserrat Garcia-Closas; Melissa A Troester; Ying Qi; Anita Langerød; Meredith Yeager; Jolanta Lissowska; Louise A Brinton; Robert Welch; Beata Peplonska; Daniela S Gerhard; Inger Torhild Gram; Vessela N Kristensen; Anne-Lise Børresen-Dale; STEPHEN CHANOCK; Charles M Perou
Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(11):2269-75.
2007: Anita Langerød; Hongjuan Zhao; Ørnulf Borgan; Jahn M Nesland; Ida R K Bukholm; Tone Ikdahl; Rolf Kåresen; Anne-Lise Børresen-Dale; Stefanie S Jeffrey
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.
Breast cancer research : BCR 2007;9(3):R30.
2007: STEPHEN CHANOCK; Laurie Burdett; Meredith Yeager; Victor Llaca; Anita Langerød; Shafaq Presswalla; Rolf Kaaresen; Robert L Strausberg; Daniela S Gerhard; Vessela N Kristensen; Charles M Perou; Anne-Lise Børresen-Dale
Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas.
Breast cancer research : BCR 2007;9(1):R5.
2006: Magali Olivier; Anita Langerød; Patrizia Carrieri; Jonas Bergh; Sigrid Klaar; Jorunn Eyfjord; Charles Theillet; Carmen Rodriguez; Rosette Lidereau; Ivan Bièche; Jennifer Varley; Yves Bignon; Nancy Uhrhammer; Robert Winqvist; Arja Jukkola-Vuorinen; Dieter Niederacher; Shunsuke Kato; Chikashi Ishioka; Pierre Hainaut; Anne-Lise Børresen-Dale
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(4):1157-67.
2006: Lars O Baumbusch; Simen Myhre; Anita Langerød; Anna Bergamaschi; Stephanie Beate Geisler; Per Eystein Lønning; Wolfgang Deppert; Irene Dornreiter; Anne-Lise Børresen-Dale
Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.
Molecular cancer 2006;5():47.
2006: Amy V Kapp; Stefanie S Jeffrey; Anita Langerød; Anne-Lise Børresen-Dale; Wonshik Han; Dong-Young Noh; Ida R K Bukholm; Monica Nicolau; Patrick O Brown; Robert Tibshirani
Discovery and validation of breast cancer subtypes.
BMC genomics 2006;7():231.
2005: Vessela N Kristensen; Therese Sørlie; Jurgen Geisler; Anita Langerød; Noriko Yoshimura; Rolf Kåresen; Nobuhiro Harada; Per Eystein Lønning; Anne-Lise Børresen-Dale
Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 2):878s-83s.
2004: Jerry Usary; Victor Llaca; Gamze Karaca; Shafaq Presswala; Mehmet Karaca; Xiaping He; Anita Langerød; Rolf Kåresen; Daniel S Oh; Lynn Dressler; Per Eystein Lønning; Robert L Strausberg; STEPHEN CHANOCK; Anne-Lise Børresen-Dale; Charles M Perou
Mutation of GATA3 in human breast tumors.
Oncogene 2004;23(46):7669-78.
2004: Hongjuan Zhao; Anita Langerød; Youngran Ji; Kent W Nowels; Jahn M Nesland; Robert Tibshirani; Ida K Bukholm; Rolf Kåresen; David Botstein; Anne-Lise Børresen-Dale; Stefanie S Jeffrey
Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.
Molecular biology of the cell 2004;15(6):2523-36.
2003: Anita Langerød; Maria Strømberg; Koei Chin; Vessela N Kristensen; Anne-Lise Børresen-Dale
BUB1 infrequently mutated in human breast carcinomas.
Human mutation 2003;22(5):420.
2003: Ida R K Bukholm; Anne Husdal; Jahn M Nesland; Anita Langerød; Geir Bukholm
Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up time.
Breast cancer research and treatment 2003;80(2):199-206.
2002: Anita Langerød; Ida R K Bukholm; André Bregård; Per Eystein Lønning; Tone Ikdal Andersen; Torleiv O Rognum; Gunn Iren Meling; Ragnhild A Lothe; Anne-Lise Børresen-Dale
The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(12):1684-8.